Trials / Completed
CompletedNCT06288399
Prevalence and Economic Burden of Obesity-related Comorbidities in the Gulf Region: A Retrospective, Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,316 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to assess the annual prevalence of ORCs among adult people with obesity in the real-world clinical setting across the Gulf region. In addition, the study will describe the annual HCRU and associated costs of obesity and ORCs, describe the demographics and clinical characteristics of adult people with obesity, as well as estimate the annual incidence and point prevalence of the ORCs among adult people with obesity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No treatment given | No treatment given |
Timeline
- Start date
- 2023-12-21
- Primary completion
- 2024-09-30
- Completion
- 2024-09-30
- First posted
- 2024-03-01
- Last updated
- 2025-10-15
Locations
7 sites across 3 countries: Kuwait, Oman, Qatar
Source: ClinicalTrials.gov record NCT06288399. Inclusion in this directory is not an endorsement.